129 related articles for article (PubMed ID: 38304366)
1. EFFECT OF MAMMOGRAPHY IMAGING PROCEDURE ON SERUM INFLAMMATORY AND/OR TUMOR MARKER LEVELS.
Sahingoz Erdal G; Akdogan Gemici A; Cikot M; Apikoglu Rabus S; Isiksacan N; Inci E; Hursitoglu M
Acta Clin Croat; 2023 Apr; 62(1):201-207. PubMed ID: 38304366
[TBL] [Abstract][Full Text] [Related]
2. Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma.
Goldenberg DM; Abdel-Nabi H; Sullivan CL; Serafini A; Seldin D; Barron B; Lamki L; Line B; Wegener WA
Cancer; 2000 Jul; 89(1):104-15. PubMed ID: 10897007
[TBL] [Abstract][Full Text] [Related]
3. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3.
Di Gioia D; Blankenburg I; Nagel D; Heinemann V; Stieber P
Clin Chim Acta; 2016 Oct; 461():1-7. PubMed ID: 27451906
[TBL] [Abstract][Full Text] [Related]
4. Self-compression Technique vs Standard Compression in Mammography: A Randomized Clinical Trial.
Henrot P; Boisserie-Lacroix M; Boute V; Troufléau P; Boyer B; Lesanne G; Gillon V; Desandes E; Netter E; Saadate M; Tardivon A; Grentzinger C; Salleron J; Oldrini G
JAMA Intern Med; 2019 Mar; 179(3):407-414. PubMed ID: 30715083
[TBL] [Abstract][Full Text] [Related]
5. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
[TBL] [Abstract][Full Text] [Related]
6. Mammographic compression--a need for mechanical standardization.
Branderhorst W; de Groot JE; Highnam R; Chan A; Böhm-Vélez M; Broeders MJ; den Heeten GJ; Grimbergen CA
Eur J Radiol; 2015 Apr; 84(4):596-602. PubMed ID: 25596915
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
[TBL] [Abstract][Full Text] [Related]
8. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.
Lukaszewicz-Zając M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
Clin Exp Med; 2011 Jun; 11(2):89-96. PubMed ID: 20938721
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of tumour marker velocity of cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in breast cancer surveillance.
Hing JX; Mok CW; Tan PT; Sudhakar SS; Seah CM; Lee WP; Tan SM
Breast; 2020 Aug; 52():95-101. PubMed ID: 32485607
[TBL] [Abstract][Full Text] [Related]
10. The immunoscintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer.
Lind P; Smola MG; Lechner P; Ratschek M; Klima G; Költringer P; Steindorfer P; Eber O
Int J Cancer; 1991 Apr; 47(6):865-9. PubMed ID: 2010229
[TBL] [Abstract][Full Text] [Related]
11. Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer.
Uehara M; Kinoshita T; Hojo T; Akashi-Tanaka S; Iwamoto E; Fukutomi T
Int J Clin Oncol; 2008 Oct; 13(5):447-51. PubMed ID: 18946756
[TBL] [Abstract][Full Text] [Related]
12. Serum Markers CA125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of Lung Cancer in High-Risk Populations.
Li G; Zhang H; Zhang L; Liu H; Li S; Wang Y; Deng X
Biomed Res Int; 2022; 2022():1394042. PubMed ID: 36299704
[TBL] [Abstract][Full Text] [Related]
13. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
[TBL] [Abstract][Full Text] [Related]
14. The utility of serum tumor markers CEA and CA 15-3 for breast cancer prognosis and their association with clinicopathological parameters.
Uygur MM; Gümüş M
Cancer Treat Res Commun; 2021; 28():100402. PubMed ID: 34082362
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of combined scintimammography and tumor markers in breast cancer patients.
Mangkharak J; Patanachak C; Podhisuwan K; Pleehachinda R
Anticancer Res; 1997; 17(3B):1611-4. PubMed ID: 9179203
[TBL] [Abstract][Full Text] [Related]
16. Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic.
Dontchos BN; Achibiri J; Mercaldo SF; Wang GX; Lamb LR; Miles RC; Narayan AK; Lehman CD
AJR Am J Roentgenol; 2022 Feb; 218(2):270-278. PubMed ID: 34494449
[No Abstract] [Full Text] [Related]
17. Study of correlation between biochemical indicators and radiological diagnostic parameters of breast cancer.
Orujova IN; Azizova GI; Gafarov IA; Orujov AH
Klin Lab Diagn; 2020 Dec; 65(12):738-743. PubMed ID: 33373504
[TBL] [Abstract][Full Text] [Related]
18. The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort.
Olson JE; Sellers TA; Scott CG; Schueler BA; Brandt KR; Serie DJ; Jensen MR; Wu FF; Morton MJ; Heine JJ; Couch FJ; Pankratz VS; Vachon CM
Breast Cancer Res; 2012 Nov; 14(6):R147. PubMed ID: 23152984
[TBL] [Abstract][Full Text] [Related]
19. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
[TBL] [Abstract][Full Text] [Related]
20. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
Guadagni F; Ferroni P; Carlini S; Mariotti S; Spila A; Aloe S; D'Alessandro R; Carone MD; Cicchetti A; Ricciotti A; Venturo I; Perri P; Di Filippo F; Cognetti F; Botti C; Roselli M
Clin Cancer Res; 2001 Aug; 7(8):2357-62. PubMed ID: 11489813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
